Progestin-associated shift of meningioma mutational landscape

Abstract

BackgroundMeningiomas are the most common primary tumor of the central nervous system. The relationship between meningioma and progestins is frequently mentioned but has not been elucidated. Patients and methodsWe identified 40 female patients operated for a meningioma after long-term progestin therapy and performed targeted next generation sequencing to decipher the mutational landscape of hormone-related meningiomas. A published cohort of 530 meningiomas in women was used as a reference population. ResultsCompared with the control population of meningiomas in women, progestin-associated meningiomas were more frequently multiple meningiomas [19/40 (48%) versus 25/530 (5%), P<10−12] and located at the skull base [46/72 (64%) versus 241/481 (50%), P=0.03]. We found a higher frequency of PIK3CA mutations [14/40 (35%) versus 18/530 (3%), P<10−8] and TRAF7 mutations [16/40 (40%) versus 140/530 (26%), P<0.001] and a lower frequency of NF2-related tumors compared with the control population of meningiomas [3/40 (7.5%) versus 169/530 (32%), P<0.001]. ConclusionThis shift in mutational landscape indicates the vulnerability of certain meningeal cells and mutations to hormone-induced tumorigenesis. While the relationship between PIK3CA mutation frequency and hormone-related cancers such as breast and endometrial cancer is well-known, this hormonally induced mutational shift is a unique feature in molecular oncology.